Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of News

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>

29 January 2013: UCL students give team from Langdon Park School a taste of Citrus Saturday

Students from UCL have introduced a team from the Langdon Park School, a community sports college in East London, to the highs and lows of running their own business. More...

9 January 2013: Professor Andrew Eder appointed Associate Vice-Provost (Enterprise)

Professor Andrew Eder has been appointed Associate Vice-Provost (Enterprise) at UCL and Director of CPD and Short Course Development. More...

<< 2012 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2014 >>